BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Ado-Trastuzumab Emtansine
Related studies linked through entity extraction aliases.
4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx
- Status
- COMPLETED
- Phase
- PHASE1
HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab in Combination With Trastuzumab, or Ado-Trastuzumab Emtansine
- Status
- COMPLETED
- Phase
- N/A